2023 - FSHD Society

FDA Fast Track Designation for Avidity’s FSHD therapeutic

Posted on January 20th, 20231/20/23

What does this mean for patients? An FDA Fast Track designation DOES NOT mean that the drug has been approved for use by patients. AOC 1020 is still a long […]

Filed under: FSHD Research

(Cautious) optimism in FSHD drug development

Posted on January 16th, 20231/16/23

Patients are critical in helping to transform optimism into reality by Ken Kahtava, Chief Business Officer, FSHD Society Breakthroughs in FSHD research have identified the primary mechanism that causes FSHD. […]

Filed under: FSHD Research